Purpose; We quantified the physiological variability of clinical and pressure-flow study vari ables in patients with symptomatic benign prostatic enlargement.
Lower urinary tract symptoms in elderly men are tradi tionally labeled prostatism. The term implies cause and rem edy, whereas in reality the condition results not only from intravesical bladder outlet obstruction caused by the en larged prostate but also from motor or sensory abnormalities of detrusor and urethral function,1 or even from habit and changes in life-style that commonly occur as men age. Pa tients and physicians are anxious to know whether the symp toms are likely to be progressive and whether there is a risk of complications, such as obstructive nephropathy, acute or recurrent urinary retention, infection, bleeding, bladder stones or other complications that directly affect patient well being.
The gold standard for treatment of patients with intracta ble urinary retention or obstructive uropathy in the upper urinary tract is still transurethral prostatectomy. In the past, physicians performed prostatectomy for all patients who presented with symptoms. Patients and physicians now have a variety of treatment modalities from which to choose. Presently, in most situations other factors must be consid ered when deciding on appropriate treatment, particularly bothersomeness of the voiding disturbances and patient pref erences for treatment. A key issue is whether the physician should focus on relieving symptoms or obstruction. Unfortu nately, lower urinary tract symptoms, prostate size, free uroflowmetry parameters and post-void residual urine are associated with obstructive voiding but the correlation with grade of obstruction is poor.2' 6 Furthermore, subjective effi cacy of treatment cannot always be extrapolated to objective efficacy. 7 A noninvasive treatm ent approach is watchful waiting. More than a third of men with lower urinary tract symptoms Accepted for publication March 29, 1996.
who remain untreated or are treated with placebo experience spontaneous improvement based on subjective criteria, and more than 20% improve based on objective criteria.7 This spontaneous improvement usually occurs within the first 6 months if at all.7 Due to the variable natural history of patients with lower urinary tract symptoms, and because new treatment modalities do not always result in such dra matic subjective and objective effects compared to prostatec tomy, inclusion of a control arm that allows quantification of these spontaneous effects is becoming increasingly important in any trial to evaluate accurately the efficacy of a new treatment modality.
Urodynamic investigation is considered to be the gold stan dard to quantify grade of bladder outlet obstruction in elderly men with lower urinary tract symptoms.8 Precise grading of obstruction is becoming increasingly important in the evalu ation and comparison of new treatment modalities in pa tients with lower urinary tract symptoms and bladder outlet obstruction. However, precise grading is relatively sensitive to the effect of normal intra-individual variability. Rosier et al showed that there is a considerable intra-individual vari ability in urodynamic pressure-flow variables when the fill ing and voiding sessions during a single urodynamic inves tigation are repeated. 9 The second voiding session resulted in better voiding in a significant number of patients (65%), with a lower detrusor pressure at maximum flow rate and a larger theoretical urethral area. 9 To compare the efficacy of new instrumental and noninva sive treatm ent modalities, and to investigate the reported spontaneous subjective and objective improvement after 6 months without active treatment, we determined the physi ological variability of clinical and urodynamic pressure-flow study variables in patients with lower urinary tract symp-1027 toms and benign prostatic hypertrophy (BPH) who were fol lowed with watchful waiting for 6 months.
PATIENTS AND METHODS
In 1992, we initiated a prospective study to evaluate clin ical and urodynamic changes in patients with lower urinary tract symptoms and BPH in whom watchful waiting was chosen. All patients were evaluated at baseline by medical history, international prostate symptom score (I-PSS), pros tate specific antigen (PSA) analysis, physical examination, including digital rectal examination and ultrasonography of the prostate, and free uroflowmetry with subsequent ultra sonographic measurement of residual urinary volume. The I-PSS consists of 7 questions (total range 0 to 35), 1 of which constitutes nocturia score (range 0 to 5). The nocturia score indicates the number of times the patient m ust awaken to urinate during the night. A separate question constitutes quality of life (range 0 to 6, a greater score indicates worse perception of urinary performance). PSA was determined with the Hybritech Tandem-E PSA assay.
Prostatic volume was calculated via the planimetric method with a Kretz Combison 330 ultrasound scanner with a multiplane 3-dimensional rectal transducer. For free uro flowmetry the Dantec Urodyn 1000 flowmeter was used. For evaluation of voiding efficiency the voided percentage, which is the relative amount of bladder contents expelled during micturition, was calculated. All patients were considered neurologically normal based on history, symptoms and phys ical examination (no motor, sensory or reflex deficits). Pa tients in whom prostatic carcinoma or other diseases beyond the prostate, influencing the lower urinary tract symptoms (for example urethral stricture or bladder neck contracture) could be expected, as well as those who had received previous treatment for lower urinary tract symptoms were excluded from the study. After clinical diagnosis of lower urinary tract symptoms and BPH, patients were informed about the treat ment options. When a urodynamic investigation showed no bladder outlet obstruction and the patient experienced rela tively few symptoms, or he was not bothered by symptoms watchful waiting was recommended besides pharmacological treatment or other minimally invasive therapies. On the other hand, patients sometimes preferred watchful waiting even when bladder outlet obstruction was confirmed. I-PSS and urodynamic pressure-flow studies before and after 6 months of watchful waiting were performed to evaluate symptomatic and urodynamic changes. Urinalysis and cul ture were negative at the pressure-flow studies.
Urodynamic pressure-flow studies were performed with an 8F transurethral lumen catheter equipped with an intraves ical microtip pressure sensor for bladder pressure recording. Abdominal pressure was recorded intrarectally with an 8F microtip sensor catheter. Before cystometry, the bladder was emptied through the lumen of the transurethral catheter. The bladder was filled with water at 20C with a filling speed of 50 ml. per minute with the patient supine. Commercially available equipment was used to record pressure and flow data.
The pressure-flow relationship during voiding was ana lyzed by a graph of flow and detrusor pressure, with pressure projected on the y axis and flow on the x axis. A pressure-flow graph near the y axis, indicating a high pressure th at gen erates a low flow, is the result of more obstructed voiding than a graph near the x axis. Visual evaluation of a pressureflow graph allows for a rough estimation of grade of obstruc tion. However, for an objective and quantitative definition of the pressure-flow relationship we used the passive urethral resistance relation analysis and urethral resistance factor. With passive urethral resistance relation analysis, a quad ratic curve, the passive urethral resistance relation curve, is fitted to the lowest pressure portion of the pressure-flow graph, which is normally the phase of voiding subsequent to maximum flow ( fig. l ).10j11 The detrusor pressure at maxi mum flow during the urodynamic investigation was re corded. The passive urethral resistance relation param eter of minimal urethral opening pressure during micturition was observed at the end of voiding* The theoretical cross-sectional urethral lumen was computed from the slope of the passive urethral resistance relation curve.11 A steep curve with a slight angle to the pressure axis reflected a narrow urethral cross-sectional area. Griffiths et al found a statistical corre lation between theoretical cross-sectional urethral lumen and minimal urethral opening pressure during voiding. 12 This correlation was used to decrease both parameters to 1 urethral resistance factor. Urethral resistance factor quanti fies obstruction by computing a preset curve with a fixed theoretical cross-sectional urethral lumen-to-minimal ure thral opening pressure during voiding ratio, through the point of detrusor pressure at maximum flow.
The digitally stored pressure and flow data were tran s lated to a urodynamic analysis computer program developed by the research center at our department. This program provides a semiautomatic pressure-flow study analysis with passive urethral resistance relation and urethral resistance factor analysis. The minimal urethral opening pressure dur ing voiding and theoretical cross-sectional urethral lumen were calculated automatically based on the manually ad justed passive urethral resistance relation curves. Correction for flow artifacts was performed when necessary. We also added a nonparametric analysis of obstruction with clinical classes according to the linear passive urethral resistance relation pressure-flow nomogram ( fig. I ).11 The linear pas sive urethral resistance relation was determined by drawing a straight line between the detrusor pressure at maximum flow and the minimal urethral opening pressure during void ing points on the pressure-flow curve. The position of this line defined the outlet condition in a simple manner and afforded classification of the severity of bladder outlet obstruction. Urodynamic variables analyzed included free maximum flow rate, free voided volume, residual volume after free flowmetry and free voided percentage according to free flowmetry, bladder capacity at cystometry, maximum flow at urodynamic investigation, detrusor pressure at maximum flow, minimal urethral opening pressure during voiding, the oretical cross-sectional urethral lumen, urethral resistance factor, residual volume after uro dynamic pr ess ur e-flow study and voided percentage at pressure-flow study according to pressure-flow studies. Variables were investigated for the entire group of patients and for subgroups categorized without (linear passive urethral resistance relation class 1 or less), with moderate (linear passive urethral resistance rela tion class 2 or 3) or with obvious (linear passive urethral resistance relation class 4 or more) bladder outlet obstruc tion.
Statistical analysis was performed using the Wilcoxon matched pairs signed rank test for analysis of numerical data and the Krus kal-Wallis 1-way analysis of variance to com pare baseline characteristics among groups. The Spearman correlation coefficient was calculated to correlate bladder capacity and detrusor pressure at maximum flow.
RESULTS
From January 1992 to November 1994, 750 new patients with lower urinary tract symptoms and BPH were referred to our clinic for evaluation: 17% were treated with transure thral thermotherapy, 20% were treated surgically (laser, transurethral or open prostatectomy, or bladder neck inci sion), 37% received medication (a l blockers or 5a-reductase inhibitors), 2% were treated with intermittent or suprapubic catheterization, and 24% (178) chose watchful waiting* Four of the latter 178 patients were excluded from analysis be cause the initial linear passive urethral resistance relation category could not be assessed. No pressure-flow study was done in 1 patient because he was unable to produce any flow at the initial intended voiding. Three patients lost the trans urethral (pressure recording) catheter during the initial void ing. The baseline characteristics of all 174 patients studied, and subgroups without (44%), with moderate (36%) and with obvious (20%) bladder outlet obstruction are indicated in table 1. In patients with obvious bladder outlet obstruction the baseline mean prostatic volume was significantly larger (p = 0.02), while mean free voided volume (p = 0.01), free maximum flow rate (p < 0.01), bladder capacity (p < 0.01) and maximum flow at urodynamic investigation (p < 0.01) were significantly smaller, A total of 53 patients was not urodynamically evaluable at month 6 because they were lost to followup (31), refused the second urodynamic evaluation (19) , began pharmacological treatment (2) or underwent surgery (1 ) . In figure 2 the initial I-PSS total symptom score and initial detrusor pressure at maximum flow, labeled according to the reason for dropping out of the study before month 6, are plotted for each individual. This scatterplot indicates that for these variables patients who were lost to followup or who refused the second clinical and pressure-flow study eval uation were heterogeneously distributed among those who completed watchful waiting for 6 months.
We evaluated 121 patients clinically and uro dynamically after 6 months (median 26 weeks, mean 31, range 19 to 116) of watchful waiting ( fig. 3 ). Analysis of the pressure-flow relationship on the clinical nomogram11 showed that 47% of these patients had no, 35% had moderate and 18% had ob vious bladder outlet obstruction. Mean urodynamic vari ables, and median symptom scores at baseline and after 6 months of watchful waiting for the 121 patients who com pleted watchful waiting for 6 months are indicated in table 2, as are the percentages of patients with a larger or smaller result at the second voiding, At the second free flowmetry, 59% of the patients voided with a smaller volume and, con sequently, 58% voided with a decreased free maximum flow rate compared to the first free flowmetry. There was almost no difference in mean maximum flow at urodynamic investi gation (0.1 ml. per second) but a significant number of pa tients (59%) voided with a lower detrusor pressure at maxi mum flow rate the second time. Bladder capacity and detrusor pressure at maximum flow decreased statistically significantly at the second voiding. Calculation with the Spearman correlation coefficient showed that there was no significant correlation (r = -0.15, p = 0.10) between bladder capacity and detrusor pressure at maximum flow. Further more, patients with a smaller voided volume at the second urodynamic investigation (59%) had a mean decrease in de trusor pressure at maximum flow of 15.2 cm. water, while those with a larger voided volume (42%) had a mean decrease of 17.1 cm. water. When the theoretical urethral area and urethral resistance factor were considered, no significant mean differences were shown at the second voiding. A sta tistically significant number of patients had improved total I-PSS, improved I-PSS nocturia score and improved I-PSS quality of life score after 6 months of watchful waiting. How ever, mean improvement was clinically not relevant. Table 3 shows the mean individual absolute differences, that is the positive difference resulting from the subtraction of both voidings. The mean absolute difference plus or minus standard deviation in maximum flow at urodynamic investi- Table 1 
. Mean and median (symptom scores and linear passive urethral resistance relation category) baseline characteristics in 174 patientsj and for subgj^oups withoutt with moderate and with obvious bladder outlet obstruction
4 (4-6)* 2 (0-6) * Statistically significant difference (p <0.05) in baseline characteristics among 3 groups without, with moderate and with obvious bladder outlet obstruction. r   20  22  24  26  28  30  32  34  37  39  44  56  63  68  91  21  23 25  27  29  31  33  35  38  43  54  60  65  75 116 Follow-up time 2nd urodynamic study (weeks) gation between both voidings was 2.3 ± 2.1 ml. per second. Values of extreme, large and small differences are shown in this table, as well as the number of patients exceeding these differences. In 50 patients (42%) the difference in maximum flow at urodynamic investigation between both voidings was more than 2.0 ml. per second and in 36 (30%) there were only slight differences (less than 1 ml. per second). Mean maxi mum flow at urodynamic investigation in patients with ex treme differences did not change significantly. In the entire group mean maximum flow at urodynamic investigation was 8.9 ±3.8 ml. per second initially and 8.8 ± 3.7 ml. per second at the second study. In the group with extreme differences mean maximum flow at urodynamic investigation was 8.9 ± 3.9 ml. per second initially and 9.4 ± 3.8 ml. per second a t the second study. When evaluating patients with extreme differ ences of detrusor pressure at maximum flow, it appeared 
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S. Mean individual absolute differences in symptoms and urodynamic results} and number of patients with clinically extreme, clinically large and slight differences among 121 who completed the second clinical and urodynamic pressure-flow study
Mean Absolute Difference ± SD that they had either an extreme small or an extreme large detrusor pressure at maximum flow at the initial voiding.
Patients with extreme differences in theoretical crosssectional urethral lumen were mainly those with an extreme large theoretical cross-sectional urethral lumen at the initial voiding. When we performed the statistical analysis without the patients with extreme values as indicated in table 3 the mean results remained unchanged, indicating that extreme differences in the entire group of patients occurred at the same magnitude in the negative and positive directions.
In table 4 , the clinical and urodynamic parameters at base line and after 6 months of watchful waiting are shown for 12 1 patients, grouped by linear passive urethral resistance rela tion. In patients without bladder outlet obstruction total I-PSS, I-PSS nocturia score and I-PSS quality of life score improved significantly. These improvements were slight and clinically not relevant. In the group with moderate bladder outlet obstruction the improvements in total I-PSS, I-PSS nocturia score and I-PSS quality of life score were also sta tistically significant but clinically irrelevant. In the group with obvious bladder outlet obstruction a significant im provement in total I-PSS, I-PSS nocturia score and I-PSS quality of life score could not be shown. Mean free voided volume and free maximum flow rate were decreased at the second voiding but the differences were not statistically sig nificant in the 3 groups. Compared to the first result, the second mean detrusor pressure at maximum flow was 5.2 cm. water larger (p = 0.18) in the group without bladder outlet obstruction, 9.7 cm. water smaller (p <0.01) in the group with moderate obstruction and 14.1 cm. water smaller (p = 0.01) in the group with obvious bladder outlet obstruction. When patients with extreme differences in detrusor pressure at maximum flow (table 3) were excluded, the differences in mean detrusor pressure at maximum flow were not signifi cant, The second mean detrusor pressure at maximum flow in the group without bladder outlet obstruction was then 1.7 cm. water larger (p = 0.46) and in the group with moderate obstruction it was 9.0 cm. water smaller (p <0.01), while in the group with obvious bladder outlet obstruction the second mean detrusor pressure at maximum flow was 5.6 cm. water smaller (p = 0.1 1 ).
Compared to the first result, the second mean minimal urethral opening pressure during voiding and urethral resis tance factor were 0.5 and 2.8 cm. water larger in the group without bladder outlet obstruction (p = 0.99 and p = 0.02, respectively), and 4.9 and 3.1 cm. water smaller in the group with moderate bladder outlet obstruction (p = 0.03 and p = 0.08, respectively). In the group with obvious bladder outlet obstruction the second mean minimal urethral opening pres sure during voiding and urethral resistance factor were 5.1 and 7.0 cm. water smaller (p -0.52 and p ~ 0.02, respec tively). Mean theoretical cross-sectional urethral lumen did not change significantly. The second mean theoretical crosssectional urethral lumen was 0.35 mm.2 smaller in the group without bladder outlet obstruction (p = 0.23), 0.47 mm.2 larger in the group with moderate obstruction (p = 0.29) and 0.24 mm.2 larger in the group with obvious bladder outlet obstruction (p = 0.14). Although the median linear passive urethral resistance relation in the group without bladder outlet obstruction remained unchanged (class 1 ) the second linear passive urethral resistance relation category was larger in 22 patients, smaller in 10 and unchanged in 22. This difference was statistically significant (p = 0.01). In the group with moderate bladder outlet obstruction the median Table 4 linear passive urethral resistance relation classification re mained unchanged (class 2). The second linear passive ure thral resistance relation category in these patients was greater in 10, smaller in 18 and the same in 13 (p = 0.05), In the group with obvious bladder outlet obstruction the median linear passive urethral resistance relation changed from 4 ;e 4 to 5) to 3 (range 2 to 4), which was significant. Of these patients 14 had a smaller linear passive urethral re sistance relation at the second voiding, 7 remained un changed and none had a larger value (p < 0* 01),
. Mean and median (symptom scores and linear passive urethral resistance relation classification) variables at baseline and after 6 months of watchful waiting in 121 patients who completed the second urodynamic evaluation
After evaluation at month 6, 102 patients (84%) contin ued watchful waiting, 9 began pharmacological treatm ent, 4 underwent transurethral microwave therm otherapy and 6 underwent surgery. Thereafter, 66 patients were fol lowed for a median of 31.4 weeks (range 1 to 97), during which time 2 underwent surgery and 2 began pharmaco logical treatment. In figure 4 the initial detrusor pressure at maximum flow and total I-PSS are indicated for each individual, with a followup of longer than 6 months, la beled according to the last treatm ent policy: surgery in 9, transurethral thermotherapy in 4, pharmacological tre a t ment in 16 and watchful waiting in 114. This figure indi cates th at all patients who underwent surgery or who received transurethral thermotherapy had a large initial detrusor pressure a t maximum flow (all but 1 had an initial detrusor pressure at maximum flow of more than 55 cm. water), and th at patients who received pharmacological treatm ent had a small initial detrusor pressure at maximum flow (all but 1 had an initial detru sor pressure at maximum flow of less than 55 cm. water). Initial total I-PSS values were heterogeneously distributed among the different treatm ent options. 
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DISCUSSION
Urodynamic investigation with pressure-flow study and symptom scores enabled us to investigate the relationship between objective and subjective efficacy of treatment. Pre viously, when the therapeutic choice was limited to surgery or watchful waiting, pressure-flow evaluation was simply used to diagnose bladder outlet obstruction. Because new, less invasive treatment modalities are now available, precise grading of obstruction is increasingly important in the eval uation of treatment efficacy. 13 The clinical nomogram used in our study has 7 obstruction categories, and is more detailed than a diagnosis of obstruction or no obstruction.11 Pressureflow evaluation is able to provide a continuous numeric scale of obstruction and, therefore, is even more refined. Further more, stratification of therapeutic options based on the indi vidual, accurately assessed, grade of obstruction has recently become available.14»15 For a reliable assessment of grade of obstruction on a numeric scale, it is essential th at the test result is accurate and reproducible. The accuracy and repro ducibility of a test can be determined by repeating it directly after the test has been done, and by repeating it at different times or with different equipment depending on the circum stances. Rosier et al showed that the test result of pressureflow studies is reproducible, with only slight variability when the filling and voiding session during a single urodynamic pressure-flow study is repeated. 9 We studied the intra individual variability of the test results of symptom scores and pressure-flow studies when the test was repeated after 6 months without treatment.
When evaluating the total investigated group of patients and comparing our results with those of Rosier et al,9 the mean changes in detrusor pressure at maximum flow, max imum flow at urodynamic investigation and urethral resis tance factor were comparable. In the study of Rosier et al 63% of the patients voided the second time with a smaller detru sor pressure at maximum flow, and the mean difference of 3.0 cm. water was statistically significant.9 In our study 59% of patients voided the second time with a smaller detrusor pressure at maximum flow, and the mean difference of 3.7 cm. water was statistically significant. However, the mean difference in theoretical cross-sectional urethral lumen in the study of Rosier et al was 0.36 mm.2, which was statistically significantly larger the second time,9 while in our study there was only an insignificant difference of 0.04 mm.2.
Regarding the variations of pressure-flow study variables in our study, the percentages of patients with extreme or large differences of urodynamic pressure-flow study vari ables was greater but the mean pressure-flow study variables were not relevantly different (table 3) . However, there was a statistically significantly smaller detrusor pressure at max imum flow and bladder capacity at the second evaluation (table 2) . However, the magnitude of the changes in detrusor pressure at maximum flow and bladder capacity was slight and the clinical relevance must be questioned. A smaller bladder capacity may theoretically result in decreased pres sure at micturition with a smaller detrusor pressure at max imum flow. Therefore, we calculated the Spearman correla tion coefficient in our patients. There appeared to be no significant correlation (r = -0.15, p -0.10) between bladder capacity and detrusor pressure at maximum flow. Further more, 62 patients with a smaller voided volume at the second urodynamic investigation had a mean decrease in detrusor pressure at maximum flow of 15.2 cm. water, while those with a larger voided volume at the second urodynamic inves tigation had a mean decrease of 17.1 cm. water. This finding indicates that in our study it is not likely that a smaller bladder capacity is the important factor resulting in a de creased detrusor pressure at maximum flow.
Rosier et al studied relatively more patients with an in creased grade of bladder outlet obstruction and, therefore, we must be cautious when drawing conclusions from a compar ison of, in essence, 2 different populations.9 The greater vari ability found in our study could be due to the variations in the dynamic component as described by Caine. 16 Caine sug gested that a combination of mechanical and dynamic com ponents has a significant impact on lower urinary tract symptoms. The mechanical component, that is the enlarged prostate gland, does not spontaneously decrease with time. 17 In contrast, the dynamic component is subject to rapid changes depending on a variety of factors that influence sympathetic activity. Among these factors, stress, cold and use of sympathomimetic agents can increase clinical symp toms, indicating th at these dynamic components probably involve the smooth muscle tone in the prostate, prostate capsule and bladder neck. [16] [17] [18] With a longer interval be tween investigations the dynamic component may have a greater impact on the differences between the test results.
The values at baseline confirm that patients with obvious bladder outlet obstruction have decreased maximal flow rates. In our study patients with obvious bladder outlet ob struction also had significantly decreased free voided vol umes and a significantly smaller bladder capacity. In the obvious bladder outlet obstruction group a free voided vol ume of 230 ± 108 ml. indicates that, although they are instructed to present to the outpatient clinic with a full bladder, a considerable percentage of patients have an initial voided volume of less than 150 ml., which is a cutoff point frequently used as a selection criterion in clinical trials. Evidently, some patients with obvious bladder outlet obstruc tion do not enter these trials, while the largest urodynamic treatment responses are reported in those with low maximal flow rates. 19 Consequently, the study results may not be linearly extrapolated to the population. In fact, clinical trials in patients with a free voided volume of 150 ml. or more may underestimate the urodynamic treatment responses that could be detected in the population.
At the second free flowmetry study 59% of the patients voided with a smaller volume and, consequently, 58% voided with a decreased free maximum flow rate compared to the first study. When comparing the free voided volumes with free maximum flow rate using the Liverpool nomograms, it appeared that the values of the first voiding, that is voided volume 314 ml. and free maximum flow rate 13.2 ml. per second, correspond with the 7th percentile, while the values of the second voiding, th at is voided volume 257 ml, and free maximum flow rate 12.1 ml. per second, correspond with the 8th percentile of the healthy men investigated.20 This finding indicates th at the changes in flow rates were merely a result of changes in voided volumes.
The pro static volume in patients with obvious bladder out let obstruction was significantly larger, confirming the sta tistically significant although moderate correlation between prostate size and bladder outlet obstruction.5-6
After 6 months of watchful waiting, total I-PSS was signif icantly less in 64% of the patients, I-PSS nocturia score was significantly less in 34% and I-PSS quality of life score was significantly less in 51%, confirming that subjective dif ferences do not always correlate with objective differences in urodynamic variables.7 In patients without bladder outlet obstruction all subjective tests were statistically significantly improved after 6 months of watchful waiting. In patients with moderate bladder outlet obstruction only total I-PSS and I-PSS nocturia score were statistically significantly improved. One may argue that the subjective difference after 6 months of watchful waiting in patients without and with moderate bladder outlet obstruction was statistically signif icant but clinically irrelevant, although it is remarkable that in those with obvious obstruction no subjective improve ment was shown. There was not even a tendency for im provement in total I-PSS and I-PSS nocturia score. This finding confirms the results of the Veterans Affairs Cooper ative Study on transurethral resection of the prostate versus watchful waiting.21 In this study the symptomatic patients were randomized for either watchful waiting or surgery. In the watchful waiting group 30 to 40% of the patients showed symptomatic improvement. This group may, in fact, be pa tients without bladder outlet obstruction (44% of our patients). The authors concluded that watchful waiting is usually a safe alternative for men who are less bothered by urinary difficulty or who wish to delay surgery. We agree with their conclusion because we have shown th at in pa tients with obvious bladder outlet obstruction symptoms may not improve but certainly they do not worsen. More over, the urodynamic status after 6 months of watchful waiting in patients with obvious bladder outlet obstruction does not seem to worsen. However, the long-lasting urody namic effect in patients with obvious bladder outlet ob struction is still uncertain. Hopefully, we will be able to extend our study and to repeat the investigations in some patients who remained on watchful waiting to evaluate the natural history of lower urinary tract symptoms and BPH with or without bladder outlet obstruction. However, with time more patients will be lost to followup or treated as shown in figure 4 .
At our center, patients with a large initial detrusor pres sure at maximum flow were treated with transurethral ther motherapy or surgery, while those with a low initial detrusor pressure at maximum flow were treated pharmacologically. The initial symptom scores were heterogeneously distributed among the different treatment options. Apparently, for the physicians at our center the results of pressure-flow studies rather than symptom scores have an important role in deter mining choice of therapy ( fig. 4) .
The changes in mean pressure-flow variables among the 3 linear passive urethral resistance relation groups were re markably different. Patients without bladder outlet obstruc tion had changes indicating more obstruction, while those with bladder outlet obstruction initially had less obstruction. The increases of mean urethral resistance factor and mean linear passive urethral resistance relation in patients with out bladder outlet obstruction were slight but statistically significant. The decreases in mean detrusor pressure at max imum flow and mean minimal urethral opening pressure during voiding in patients with moderate bladder outlet ob struction were significant, and the decreases in mean detru sor pressure at maximum flow, urethral resistance factor and linear passive urethral resistance relation in patients with obvious bladder outlet obstruction were significant. Even mean residual volume and mean voided percentage at pressure-flow study improved significantly in patients with obvious bladder outlet obstruction. The difference in mean detrusor pressure at maximum flow in patients with obvious obstruction was 14.1 cm. water, which comes close to the suggested clinically relevant cutoff point for differences in pressure classes of 15 cm. water.9 These findings could be explained by regression towards the mean, a statistical phe nomenon in which, if a followup sample is chosen based on extreme scores, the retest scores will tend to be closer to the population mean than the initial scores. As suggested by Caine,16 numerous varying factors may influence the dy namic part of the obstruction, and these factors may occa sionally combine to produce a result that is either extremely large or extremely small. When measurements are repeated, it is unlikely that components that involve a random element should combine again in this extreme fashion. Large values accordingly tend to decrease, while small values tend to increase. Just as these extreme values tend to regress to the population mean on reexamination, patients with chronic but fluctuating conditions tend to seek medical attention in the "bad" periods during exacerbations. Consequently, the condi tion is more prone to improve than to deteriorate further regardless of the treatment instituted.
We compared the previously reported urodynamic treat ment efficacy of new instrum ental and noninvasive therapies to the physiological variability reported in our study. After laser prostatectomy, an individual mean improvement in detrusor pressure at maximum flow of 37 cm. water was reported.22 This result is unequivocal and larger than the expected physiological variability. After transrectal high in tensity focused ultrasound and transurethral thermotherapy of the prostate, statistically significant improvements in mean detrusor pressure at maximum flow of 1 1 and 10 cm. water have been reported.23-24 Based on our results, these findings could be obtained simply by repeating the urody namic pressure-flow evaluation after 6 months without th er apy. Tammela and Kontturi reported a mean decrease in detrusor pressure at maximum flow of 39 cm. water after finasteride treatment for 6 months and a mean increase in detrusor pressure at maximum flow of 3 cm. water in the placebo group, indicating a significant response to treat ment. 25 The results of this study conflict with our results. Considering the large mean detrusor pressure at maximum flow in the study by Tammela and Kontturi (120 cm. water), the majority of the patients studied had severe bladder outlet obstruction, and we would also expect a decrease in detrusor pressure at maximum flow in the placebo group. 25 The uro dynamic response in a study evaluating the efficacy of dox azosin, an a l selective blocker, although significantly better compared to placebo treatment, was slight (improvement in detrusor pressure at maximum flow 5 cm. water) and within physiological variability. 26 These findings indicate that mean differences among therapy groups must be regarded criti cally) particularly when the reported differences are slight and possibly within physiological variability. The variability of pressure-flow parameters in our study was greater than in a previous study when the filling and voiding session was repeated during a single urodynamic pressure-flow evalua tion. However, mean pressure-flow parameters were only slightly different. This finding indicates that the dynamic component of obstruction actually exists and should be con sidered in the evaluation of new treatm ent modalities for patients with lower urinary tract symptoms and BPH. CONCLUSIONS We demonstrated th at patients without bladder outlet ob struction experienced statistically significant but slight symptomatic improvement after 6 months of watchful w ait ing. Symptoms of patients with obvious bladder outlet ob struction did not improve significantly. From a clinical and diagnostic viewpoint, the reproducibility of mean pressureflow study results after 6 months of watchful waiting was evident. However, there was an important intra-individual variability. Patients with extreme values at the initial pressure-flow study tended to experience regression towards the mean of the population at the second evaluation. Patients with obvious bladder outlet obstruction showed a significant decrease in detrusor pressure at maximum flow of 14 cm. water, a significant decrease in urethral resistance factor of 7 cm, water and a significant decrease of 1 obstruction class on the linear passive urethral resistance relation nomogram, indicating less severe bladder outlet obstruction. Mean dif ferences among therapy groups m ust be regarded critically, particularly when the reported differences are slight and possibly within physiological variability. Due to the physio logical variability caused by the dynamic component of ob struction, any clinical trial evaluating a new treatment mo dality should include a control arm th a t allows quantification of this physiological variability.
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